STOCK TITAN

Palomino Laboratories (PALX) Stock News

PALX OTC

Welcome to our dedicated page for Palomino Laboratories news (Ticker: PALX), a resource for investors and traders seeking the latest updates and insights on Palomino Laboratories stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Palomino Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Palomino Laboratories's position in the market.

Rhea-AI Summary

Palomino Laboratories (OTCQB: PALX) has shipped its first GaN MicroLED light engine prototypes to a first hyperscaler customer, which independently measured bandwidth performance exceeding Palomino’s initial design targets. The company is investing in R&D to further improve bandwidth, efficiency and power.

According to Palomino, it remains on track to sample 2nd generation MicroLED technology with improved bandwidth to multiple customers by the end of Q3 FY26 and expects its first development contract from a strategic AI customer in Q4 FY26. The company also references a recently announced LOI to acquire Vega Links to evolve from device supply toward differentiated optical links for AI interconnects, targeting bandwidth and efficiency bottlenecks in AI data centers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.33%
Tags
none
-
Rhea-AI Summary

Palomino Laboratories (OTCQB: PALX) signed a binding all-stock Letter of Intent to acquire Vega Links, subject to customary closing conditions. Management targets creating a next-generation AI interconnect company spanning copper, MicroVCSEL and MicroLED-based data communication solutions for AI data centers, robotics and space applications.

According to Palomino, the combination is expected to expand its estimated addressable market by about 10x, from roughly $6 billion to more than $60 billion, and broaden engineering capabilities in silicon and gallium nitride (GaN) integrated circuits. Post-closing, Palomino expects to appoint Karthik Gopalakrishnan as Chief Technology Officer and Rajesh Radhamohan as Chief Product Officer, aiming to position the company across multiple layers of the AI networking stack.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.58%
Tags
-
Rhea-AI Summary

Palomino Laboratories (OTCQB: PALX) announced that its common stock began trading on the OTCQB Venture Market under the ticker “PALX”, effective July 10, 2026. The shares are also DTC eligible, enabling electronic clearing and settlement through the Depository Trust Company.

According to Palomino, the OTCQB trading is a key milestone expected to increase its visibility among investors and support its long-term commercialization roadmap and pursuit of a future national exchange listing. The company continues developing optical interconnect technologies aimed at higher bandwidth, lower latency and reduced power consumption for AI, HPC and data center networking.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Palomino Laboratories (OTCQB: PALX) announced that Co-Founder Dr. Steven P. DenBaars received the 2026 IEEE Nick Holonyak Jr. Medal on April 25, 2026, for contributions to compound semiconductor optoelectronics.

The company also noted its recent OTCQB listing and highlighted Dr. DenBaars’ III-nitride research as foundational to Palomino’s energy-efficient optical interconnect technology for AI data centers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Palomino Laboratories (OTCQB: PALX) closed a private placement on April 27, 2026, raising $15,095,412 by selling 3,773,853 common shares at $4.00 per share. The company says the proceeds will fund commercialization and scaling of its GaN MicroLED optical interconnect technology for AI data centers and align with CHIPS/NIST priorities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Palomino Laboratories (PALX)?

The current stock price of Palomino Laboratories (PALX) is $12.55 as of July 28, 2026.